Jiangsu Vcare

Nanjing, China · Founded 2010 · Privately Held (backing)

Developer of innovative drugs designed to treat cardiovascular and cerebrovascular, tumors, endocrine, and other areas of chronic diseases. Jiangsu Vcare is based in Nanjing, China and was founded in 2010. Its last reported valuation was $162 million in Feb 2021. It has raised $225 million.

Last reported valuation
$162.4M
Oct 2026
Priced at
—
Total raised
$225.4M
Last round
—

Who backs Jiangsu Vcare?

17 investors
InvestorType
Zijin Hi-Tech Venture CapitalOther
CMG SDIC FundVenture capital
Nanjing Innovation Capital GroupOther
Hubei Yangtze River Industrial Investment GroupOther
China Life Private EquityOther
Nanjing New Industry Investment GroupOther
Jinlong GroupOther
DYEE Capital—
Galaxy Ventures (China)—
Hangzhou Hongcheng Capital—
+ 7 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Jiangsu Vcare investors

Free account
More of Jiangsu Vcare with a free account
  • ·The complete investor list: 17 names
  • ·Watch Jiangsu Vcare: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 17 firms already write checks for companies like Jiangsu Vcare. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View